SNAP25 is a potential target for early stage Alzheimer’s disease and Parkinson’s disease

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
1 Online-Ressource.
Language
Englisch

Bibliographic citation
SNAP25 is a potential target for early stage Alzheimer’s disease and Parkinson’s disease ; volume:28 ; number:1 ; day:6 ; month:12 ; year:2023 ; pages:1-13 ; date:12.2023
European journal of medical research ; 28, Heft 1 (6.12.2023), 1-13, 12.2023

Classification
Medizin, Gesundheit

Creator
Wang, Qian
Tao, Sijue
Xing, Lei
Liu, Jiuyu
Xu, Cankun
Xu, Xinyi
Ding, Haohan
Shen, Qi
Yu, Xiaobo
Zheng, Yingwei
Contributor
SpringerLink (Online service)

DOI
10.1186/s40001-023-01360-8
URN
urn:nbn:de:101:1-2024022213575170212439
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 11:02 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Wang, Qian
  • Tao, Sijue
  • Xing, Lei
  • Liu, Jiuyu
  • Xu, Cankun
  • Xu, Xinyi
  • Ding, Haohan
  • Shen, Qi
  • Yu, Xiaobo
  • Zheng, Yingwei
  • SpringerLink (Online service)

Other Objects (12)

Constipation in Parkinson’s Disease: A Systematic Review and Meta-Analysis

Constipation in Parkinson’s Disease: A Systematic Review and Meta-Analysis

Parkinson’s disease and Alzheimer’s disease: a Mendelian randomization study

Parkinson’s disease and Alzheimer’s disease: a Mendelian randomization study

Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease

Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease

Incretin and insulin signaling as novel therapeutic targets for Alzheimer’s and Parkinson’s disease

Incretin and insulin signaling as novel therapeutic targets for Alzheimer’s and Parkinson’s disease

Measuring compounds in exhaled air to detect Alzheimer´s disease and Parkinson´s disease

Measuring compounds in exhaled air to detect Alzheimer´s disease and Parkinson´s disease

Gene expression meta-analysis of Parkinson’s disease and its relationship with Alzheimer’s disease

Gene expression meta-analysis of Parkinson’s disease and its relationship with Alzheimer’s disease

Correction to: Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease

Correction to: Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease

Facial emotion expressivity in patients with Parkinson’s and Alzheimer’s disease

Facial emotion expressivity in patients with Parkinson’s and Alzheimer’s disease

Role of glucagon-like peptide-1 receptor agonists in Alzheimer’s disease and Parkinson’s disease

Role of glucagon-like peptide-1 receptor agonists in Alzheimer’s disease and Parkinson’s disease

Relevance of plasma biomarkers to pathologies in Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia

Relevance of plasma biomarkers to pathologies in Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia

Development of seed amplificafion assays as biomarkers for Alzheimer’s & Parkinson’s disease

Development of seed amplificafion assays as biomarkers for Alzheimer’s & Parkinson’s disease

Towards enabling precision medicine in Alzheimer's disease and Parkinson's disease

Towards enabling precision medicine in Alzheimer's disease and Parkinson's disease

Related objects